Summit Therapeutics (SMMT) Stock Chart & Stock Price History $22.36 +0.72 (+3.33%) Closing price 04:00 PM EasternExtended Trading$22.50 +0.14 (+0.63%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Summit Therapeutics Stock Price Performance 5 Day Performance-6.04%1 Month Performance+24.79%3 Month Performance+19.71%6 Month Performance+108.84%Year-To-Date Performance+25.14%1 Year Performance+492.96% Receive SMMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SMMT Stock Chart for Thursday, January, 30, 2025 SMMT Chart by TradingView Summit Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/29/2025$23.50$21.64-7.91%$23.89$21.611.85 million shs$15.96 billion01/28/2025$23.52$23.50-0.09%$24.17$22.761.73 million shs$17.33 billion01/27/2025$23.76$23.52-1.01%$23.56$22.321.81 million shs$17.34 billion01/24/2025$24.65$23.76-3.61%$25.00$23.392.60 million shs$17.52 billion01/23/2025$23.52$24.65+4.80%$25.00$22.852.79 million shs$18.18 billion01/22/2025$22.10$23.52+6.43%$24.21$22.384.45 million shs$17.34 billion01/21/2025$19.03$22.10+16.13%$22.11$19.254.40 million shs$16.30 billion01/20/2025$19.03$19.03$19.39$18.332.59 million shs$14.03 billion01/17/2025$18.19$19.03+4.62%$19.39$18.332.59 million shs$14.03 billion01/16/2025$18.20$18.19-0.05%$18.50$17.682.14 million shs$13.41 billion Get the Latest News and Ratings for SMMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/15/2025$16.65$18.20+9.31%$18.24$17.122.57 million shs$13.42 billion01/14/2025$18.17$16.65-8.37%$18.57$16.463.25 million shs$12.28 billion01/13/2025$17.85$18.17+1.79%$18.32$17.031.78 million shs$13.40 billion01/10/2025$18.82$17.85-5.15%$18.91$16.723.31 million shs$13.16 billion01/09/2025$18.82$18.82$19.39$18.103.17 million shs$13.88 billion01/08/2025$18.16$18.82+3.63%$19.39$18.103.17 million shs$13.88 billion01/07/2025$17.47$18.16+3.95%$18.21$17.371.78 million shs$13.39 billion01/06/2025$18.24$17.47-4.22%$18.55$17.412.07 million shs$12.88 billion01/03/2025$18.35$18.24-0.60%$18.61$18.061.85 million shs$13.45 billion01/02/2025$17.84$18.35+2.86%$18.89$17.752.12 million shs$13.53 billion01/01/2025$17.84$17.84$18.31$17.172.23 million shs$13.16 billion12/31/2024$17.89$17.84-0.28%$18.31$17.172.23 million shs$13.16 billion12/30/2024$18.21$17.89-1.76%$18.15$17.531.25 million shs$13.19 billion Related Companies Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Teva Pharmaceutical Industries Stock Chart BeiGene Stock Chart Moderna Stock Chart Genmab A/S Stock Chart Viatris Stock Chart Intra-Cellular Therapies Stock Chart Catalent Stock Chart Receive SMMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SMMT) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
